Escalating Atopic Dermatitis Care Runs Into Access Barriers
Escalating atopic dermatitis treatment is failing less on clinical grounds than on access: prior authorization, step therapy, and coverage gaps stall care.
Topic
Step Therapy
Topic
Step Therapy
JAK Switch Decisions Move to Center Stage in Atopic Dermatitis
Three FDA-approved JAK-pathway agents now compete for atopic dermatitis prescriptions, and a new managed-care review weighs how d…
AJMC Spotlights Fragmented Care in Undertreated Atopic Dermatitis
AJMC frames atopic dermatitis as a story of fragmented care and silent undertreatment, withholding study specifics. Dermatology p…